There was a hive of activity at the exhibition booth shared by Livac & B.Braun at the 5th Asian Congress of Robotic and Laparoscopic Surgery in Singapore.
Contact : +61 413 227 332 
News & Articles
Livac on entrepreneur’s panel at Australian Technologies Competition 2019
Our CEO, Dr Anabela Correia, was delighted to return to the Australian Technologies Competition, this time as part of an entrepreneur’s panel discussion.
Mergermarket interviews Livac CEO, Dr Anabela Correia
Livac is actively seeking AUD $6m to support US market entry
Article by Louise Weihart – mergermarket, Sept 2019
Livac, a privately held Melbourne-based Australian developer of devices to support minimally invasive surgery (MIS), is actively seeking AUD 6m (USD 4m) from new investors to support US market entry, said CEO Anabela Correira.
LiVac achieves key milestone in US marketing entry strategy
Livac Pty Ltd, an Australian medical device company, after having completed all necessary regulatory requirements of the US Food and Drug Administration, can now proceed with supply of their organ retraction system “the LiVac™ Retractor System” in the US market.
Livac Shareholder Update
First use in robotic bariatric procedure
The first use of the LiVac™ Retractor in a robotic bariatric procedure was recently conducted in Melbourne. The LiVac™ Retractor was used for the first time with a da Vinci® robot and retracted the liver throughout the duration of the Laparoscopic Sleeve Gastrectomy case. The surgeon involved went on to apply for the LiVac™ to be listed and commercially available at his hospital.
Livac on panel at AusMedTech 2019 Conference
Livac CEO, Anabela Correia, was invited to be part of a panel at AusMedTech 2019.